Cara Therapeutics Inc

-1.23 (-4.31%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.36B
Current PE161.80
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$2.36 Million
Adjusted EPS-$0.58
See more estimates
10-Day MA$27.05
50-Day MA$21.38
200-Day MA$17.16
See more pivots

CARA Therapeutics, Inc. Stock, NASDAQ:CARA

4 Stamford Plaza, 107 Elm Street, Stamford, Connecticut 06902
United States of America
Phone: +1.203.406.3700
Number of Employees: 67


CARA Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics. Its portfolio includes opioid-based products, anesthetic-based drugs, and analgesics that targets to alleviate itch and pain. The company was founded by Derek T. Chalmers, Michael E. Lewis, and Frederique Menzaghi on July 2, 2004 and is headquartered in Stamford, CT.